Bellerophon Therapeutics Company

Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.
Technology: Cancer
Industry: PharmTech
Headquarters: Warren, New Jersey, United States
Founded Date: 2009
Employees Number: 11-50
Funding Status: IPO
Estimated Revenue: $1M to $10M

Visit Website
Register and Claim Ownership